CAS: 1353644-70-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Theliatinib REF: IN-DA01FY3JCAS: 1353644-70-8 | 98% | 122.00 €~676.00 € | Tue 29 Apr 25 |
 | Theliatinib REF: 54-BUP03533CAS: 1353644-70-8 | 99% | 562.00 €~1,138.00 € | Mon 28 Apr 25 |
 | Theliatinib REF: TM-T7322CAS: 1353644-70-8 | 99.67% | 52.00 €~775.00 € | Tue 06 May 25 |
 | Theliatinib (HMPL-309) REF: 3D-DEC64470CAS: 1353644-70-8 | Min. 95% | - - - | Discontinued product |
Theliatinib
CAS:1353644-70-8
Formula:
C25H26N6O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
442.51294000000007
Ref: IN-DA01FY3J
| 25mg | 206.00 € | ||
| 50mg | 250.00 € | ||
| 100mg | 562.00 € |
Estimated delivery in United States, on Tuesday 29 Apr 2025
Ref: 54-BUP03533
| 25mg | 562.00 € | ||
| 50mg | 831.00 € | ||
| 100mg | 1,138.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Theliatinib
CAS:1353644-70-8
Theliatinib: potent, selective EGFR inhibitor, anti-tumor; Ki=0.05 nM (EGFR), IC50=3 nM (EGFR), 22 nM (T790M/L858R).
Formula:
C25H26N6O2
Purity:
99.67%
Color and Shape:
Solid
Molecular weight:
442.51
Ref: TM-T7322
| 1mg | 52.00 € | ||
| 5mg | 144.00 € | ||
| 10mg | 227.00 € | ||
| 25mg | 376.00 € | ||
| 50mg | 567.00 € | ||
| 100mg | 775.00 € | ||
| 1mL*10mM (DMSO) | 159.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
Theliatinib (HMPL-309)
CAS:1353644-70-8
Theliatinib is a drug that has been shown to inhibit the growth of cancer cells …
Formula:
C25H26N6O2
Purity:
Min. 95%
Molecular weight:
442.51 g/mol
Ref: 3D-DEC64470
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
